169 related articles for article (PubMed ID: 37224426)
1. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.
Aguirre-Urizar JM; Lafuente-Ibáñez de Mendoza I; Warnakulasuriya S
Oral Dis; 2021 Nov; 27(8):1881-1895. PubMed ID: 33606345
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
4. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
5. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
6. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
7. Overestimated risk of transformation in oral lichen planus.
Cai X; Zhang J; Zhang H; Li T
Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.
Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB
J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769
[TBL] [Abstract][Full Text] [Related]
12. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
13. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
14. Oral leukoplakia: A clinicopathological study and malignant transformation.
Tovaru S; Costache M; Perlea P; Caramida M; Totan C; Warnakulasuriya S; Parlatescu I
Oral Dis; 2023 May; 29(4):1454-1463. PubMed ID: 34982498
[TBL] [Abstract][Full Text] [Related]
15. Predictors of malignant transformation in oral leukoplakia and proliferative verrucous leukoplakia: An observational prospective study including the DNA ploidy status.
Pentenero M; Castagnola P; Castillo FV; Isaevska E; Sutera S; Gandolfo S
Head Neck; 2023 Oct; 45(10):2589-2604. PubMed ID: 37563936
[TBL] [Abstract][Full Text] [Related]
16. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.
Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E
J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621
[TBL] [Abstract][Full Text] [Related]
17. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
Tarle M; Müller D; Raguž M; Lukšić I
Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation of oral proliferative verrucous leukoplakia: A systematic review and meta-analysis.
Ramos-García P; González-Moles MÁ; Mello FW; Bagan JV; Warnakulasuriya S
Oral Dis; 2021 Nov; 27(8):1896-1907. PubMed ID: 34009718
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of oral leukoplakia: a systematic review of observational studies.
Warnakulasuriya S; Ariyawardana A
J Oral Pathol Med; 2016 Mar; 45(3):155-66. PubMed ID: 26189354
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
